Prognostic Factors of Platinum-Refractory Advanced Urothelial Carcinoma Treated with Pembrolizumab.

Yasunori AkashiYutaka YamamotoMamoru HashimotoShogo AdomiKazutoshi FujitaKeisuke KibaTakafumi MinamiKazuhiro YoshimuraAkihide HirayamaHirotsugu Uemura

Published in: Cancers (2023)

ECOG-PS ≥ 2 and baseline NLR > 3 were independent risk factors for OS in patients with platinum-refractory advanced UC treated with pembrolizumab. Antibiotic exposure was not a predictor of ICI treatment response.

Keyphrases

prognostic factors
advanced non small cell lung cancer
newly diagnosed
tyrosine kinase